Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Atherosclerosis Squalene synthase (SQS; FDFT1); cyclooxygenase (COX) In vitro and mouse studies suggest a new class of trifunctional, cholesterol-limiting, anti-inflammatory, antioxidant compounds could help...

Acquiring Nycomed will transform Takeda Pharmaceutical Co. Ltd. into a complete global pharma company by combining geographically complementary marketing operations. But the Japanese pharma will need more acquisitions to get its market cap back to...